From Survival To Sustainability: Creating A Winning Strategy In An Unstable Market is starting in

The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain

In September 2014, the Agency for Healthcare Research and Quality (AHRQ) issued an Evidence Report/Technology Assessment (Number 218) providing a systematic review of the current evidence on effectiveness and harms of opioid therapy for chronic pain, focusing on long-term (>1 year) outcomes. The study concludes that evidence on long-term opioid therapy for chronic pain is very limited, but suggests an increased risk of serious harms that appears to be dose-dependent. The report states that more research is needed to understand long-term benefits, risk of abuse and related outcomes, and effectiveness of different opioid prescribing methods . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.